A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity
M. Hossein Noyan-Ashraf(University of Toronto), Mansoor Husain(Tawam Hospital), Filio Billia(University of Toronto), Eric A. Shikatani(University Health Network), Daniel J. Drucker(University of Toronto), Lisa A. Robinson(University of Toronto), Ren‐Ke Li(University Health Network), Allen Volchuk(Hospital for Sick Children), Irmgard Schuiki(University of Toronto), Jun Wu(Hainan Medical College Hospital), Ilya Mukovozov(University of Toronto)
Cited by 255
Related Papers
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
|Nature Medicine|2013|1k
The role of gut hormones in glucose homeostasis
|Journal of Clinical Investigation|2007|611
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
|Endocrine Reviews|2014|602
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
|Diabetes Care|2003|578